Contrary to the above mentioned tumor-suppressive phenotype following MERTK inhibition in CD11b + cells, the inhibition of MERTK and AXL was reported to promote colorectal cancer (CRC) progression [76]. This evidence concerns the gene MERTK and neoplasm.